{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T03:05:20Z","timestamp":1795143920436,"version":"4.10.3"},"reference-count":148,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Acute ischemic stroke is one of the leading causes of mortality and disability globally, characterized by a complex and temporally structured cascade of cellular and molecular events. Although reperfusion therapies have improved outcomes, their narrow therapeutic window and limited availability leave many patients without effective treatment, highlighting the need for effective neuroprotective strategies capable of targeting multiple interconnected pathways. Melatonin has been proposed as a potential adjunctive neuroprotective agent based on its pleiotropic properties, modulating cellular signaling networks including antioxidant, anti-inflammatory, mitochondrial stabilizing, and BBB-preserving effects. Melatonin regulates key signaling pathways, thereby coordinating cellular responses to injury in multiple stages of ischemic pathophysiology, positioning it as a potential adjunctive therapy. Preclinical studies consistently demonstrate reductions in infarct volume, preservation of neuronal architecture, and improvements in neurological outcomes. However, clinical evidence remains limited to a small number of clinical trials, which suggest safety and possible early neurological benefit but are underpowered to determine long-term efficacy. Importantly, translational gaps persist regarding optimal dosing, duration of administration, and alignment with the temporal dynamics of post-ischemic injury. This review integrates current knowledge on the cellular and molecular mechanisms underlying the potential neuroprotective actions and its role as a pleiotropic modulator of ischemic injury.<\/jats:p>","DOI":"10.3390\/cells15121084","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:00:48Z","timestamp":1781535648000},"page":"1084","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Melatonin as a Pleiotropic Modulator of Mitochondrial Function and Cellular Signaling in Ischemic Brain Injury"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7024-011X","authenticated-orcid":false,"given":"Georgina","family":"Ortiz-Mart\u00ednez","sequence":"first","affiliation":[{"name":"Medical Coordination, Hospital General de Zona No. 83, OOAD Michoac\u00e1n, Instituto Mexicano del Seguro Social (IMSS), Morelia 58260, Mexico"},{"name":"Laboratorio de Analgesia y Mecanismos del Dolor, Facultad de Atenci\u00f3n Integral en Ciencias de la salud y Asistencia Social, Universidad Michoacana de San Nicol\u00e1s de Hidalgo (UMSNH), Morelia 58030, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1830-7468","authenticated-orcid":false,"given":"Luis Fernando","family":"Ortega-Varela","sequence":"additional","affiliation":[{"name":"Laboratorio de Analgesia y Mecanismos del Dolor, Facultad de Atenci\u00f3n Integral en Ciencias de la salud y Asistencia Social, Universidad Michoacana de San Nicol\u00e1s de Hidalgo (UMSNH), Morelia 58030, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4478-7661","authenticated-orcid":false,"given":"Mar\u00eda Esther","family":"Olvera-Cort\u00e9s","sequence":"additional","affiliation":[{"name":"Laboratorio de Neurofisiolog\u00eda Cl\u00ednica y Experimental, Centro de Investigaci\u00f3n Biom\u00e9dica de Michoac\u00e1n, OOAD Michoac\u00e1n, Instituto Mexicano del Seguro Social (IMSS), Morelia 58260, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Russi-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Emergency Department, Unidad M\u00e9dica de Alta Especialidad, Hospital General, Centro M\u00e9dico Nacional La Raza, OOAD M\u00e9xico Norte, Instituto Mexicano del Seguro Social (IMSS), Mexico City 02990, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socorro Azarell","family":"Anzures-Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Unidad M\u00e9dica de Alta Especialidad No. 48, OOAD Guanajuato, Instituto Mexicano del Seguro Social (IMSS), Le\u00f3n 37320, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Ram\u00edrez-Medina","sequence":"additional","affiliation":[{"name":"Emergency Department, Hospital General Regional No. 1, OOAD Michoac\u00e1n, Instituto Mexicano del Seguro Social (IMSS), Charo 58200, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Mar\u00eda","family":"Rosas-Ponce","sequence":"additional","affiliation":[{"name":"Emergency Department, Hospital General Regional No. 1, OOAD Michoac\u00e1n, Instituto Mexicano del Seguro Social (IMSS), Charo 58200, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Cervantes-Alfaro","sequence":"additional","affiliation":[{"name":"Independent Researcher, Morelia 58000, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019","volume":"20","author":"Feigin","year":"2021","journal-title":"Lancet Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Prabhakaran, S., Gonzalez, N.R., Zachrison, K.S., Adeoye, O., Alexandrov, A.W., Ansari, S.A., Chapman, S., Czap, A.L., Dumitrascu, O.M., and Ishida, K. (2026). 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association\/American Stroke Association. Stroke.","DOI":"10.1161\/STR.0000000000000513"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/brain\/awx126","article-title":"Neuroprotection in stroke: The importance of collaboration and reproducibility","volume":"140","author":"Neuhaus","year":"2017","journal-title":"Brain"},{"key":"ref_4","first-page":"467","article-title":"1026 Experimental treatments in acute stroke","volume":"59","author":"Macleod","year":"2006","journal-title":"Ann. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","article-title":"Pathobiology of ischaemic stroke: An integrated view","volume":"22","author":"Dirnagl","year":"1999","journal-title":"Trends Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nn.2953","article-title":"Stroke research at a crossroad: Asking the brain for directions","volume":"14","author":"Iadecola","year":"2011","journal-title":"Nat. Neurosci."},{"key":"ref_7","first-page":"384750","article-title":"Melatonin and Ischemic Stroke: Mechanistic Roles and Action","volume":"2015","author":"Andrabi","year":"2015","journal-title":"Adv. Pharmacol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-079X.2004.00172.x","article-title":"Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke","volume":"38","author":"Macleod","year":"2005","journal-title":"J. Pineal Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.3390\/ijms14058924","article-title":"Melatonin-Based Therapeutics for Neuroprotection in Stroke","volume":"14","author":"Shinozuka","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10571-019-00724-1","article-title":"Pharmacological Effects of Melatonin as Neuroprotectant in Rodent Model: A Review on the Current Biological Evidence","volume":"40","author":"Tan","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCULATIONAHA.106.603431","article-title":"Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke","volume":"115","author":"Caso","year":"2007","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"(2001). Stroke Therapy Academic Industry Roundtable II (STAIR-II). Recommendations for clinical trial evaluation of acute stroke therapies. Stroke, 32, 1598\u20131606.","DOI":"10.1161\/01.STR.32.7.1598"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1540-8183.2002.tb01087.x","article-title":"Vulnerable plaque: The pathology of unstable coronary lesions","volume":"15","author":"Virmani","year":"2002","journal-title":"J. Interv. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1152\/physrev.1999.79.4.1431","article-title":"Ischemic Cell Death in Brain Neurons","volume":"79","author":"Lipton","year":"1999","journal-title":"Physiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/01.STR.0000217418.29609.22","article-title":"Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: A systematic review","volume":"37","author":"Bandera","year":"2006","journal-title":"Stroke"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrn1106","article-title":"Mechanisms, challenges and opportunities in stroke","volume":"4","author":"Lo","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ceca.2010.01.003","article-title":"Calcium, ischemia and excitotoxicity","volume":"47","author":"Szydlowska","year":"2010","journal-title":"Cell Calcium"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/nm.2399","article-title":"The immunology of stroke: From mechanisms to translation","volume":"17","author":"Iadecola","year":"2011","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.redox.2015.08.020","article-title":"Reperfusion injury and reactive oxygen species: The evolution of a concept","volume":"6","author":"Granger","year":"2015","journal-title":"Redox Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00395-009-0004-8","article-title":"Mitochondrial permeability transition pore","volume":"104","author":"Baines","year":"2009","journal-title":"Basic Res. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.2000.80.1.315","article-title":"Mitochondria and neuronal survival","volume":"80","author":"Nicholls","year":"2000","journal-title":"Physiol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1172\/JCI135530","article-title":"Immune responses to stroke: Mechanisms, modulation, and therapeutic potential","volume":"130","author":"Iadecola","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Alluri, H., Wilson, R.L., Anasooya Shaji, C., Wiggins-Dohlvik, K., Patel, S., Liu, Y., Peng, X., Beeram, M.R., Davis, M.L., and Huang, J.H. (2016). Melatonin Preserves Blood-Brain Barrier Integrity and Permeability via Matrix Metalloproteinase-9 Inhibition. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154427"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1189\/jlb.1109766","article-title":"Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells","volume":"87","author":"Jin","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s12035-017-0394-9","article-title":"Evidence that NF-\u03baB and MAPK Signaling Promotes NLRP Inflammasome Activation in Neurons Following Ischemic Stroke","volume":"55","author":"Fann","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: Biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive Astrocytes: Production, Function, and Therapeutic Potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Przykaza, \u0141. (2021). Understanding the Connection Between Common Stroke Comorbidities, Their Associated Inflammation, and the Course of the Cerebral Ischemia\/Reperfusion Cascade. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.782569"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s11739-023-03201-2","article-title":"Inflammatory biomarkers of ischemic stroke","volume":"18","author":"Tirandi","year":"2023","journal-title":"Intern. Emerg. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/jcbfm.2014.130","article-title":"Neurogenesis and inflammation after ischemic stroke: What is known and where we go from here","volume":"34","author":"Tobin","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41392-023-01688-x","article-title":"Ischemia-reperfusion injury: Molecular mechanisms and therapeutic targets","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/jcbfm.2015.45","article-title":"Targeting neutrophils in ischemic stroke: Translational insights from experimental studies","volume":"35","author":"Jickling","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.neuroscience.2008.08.028","article-title":"Inflammation and the neurovascular unit in the setting of focal cerebral ischemia","volume":"158","year":"2009","journal-title":"Neuroscience"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W","article-title":"Astrocyte glutamate transport: Review of properties, regulation, and physiological functions","volume":"32","author":"Anderson","year":"2000","journal-title":"Glia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s11064-020-02998-0","article-title":"MSCs-Derived Exosomes Attenuate Acute Brain Injury and Inhibit Microglial Inflammation by Reversing CysLT2R-ERK1\/2 Mediated Microglia M1 Polarization","volume":"45","author":"Zhao","year":"2020","journal-title":"Neurochem. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1161\/01.STR.0000086465.41263.06","article-title":"Collateral circulation","volume":"34","author":"Liebeskind","year":"2003","journal-title":"Stroke"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archneurol.2011.1175","article-title":"Brain excitability in stroke: The yin and yang of stroke progression","volume":"69","author":"Carmichael","year":"2012","journal-title":"Arch. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/nep3.39","article-title":"The dual role of microglia in ischemic stroke and its modulation via extracellular vesicles and stem cells","volume":"2","author":"Haupt","year":"2024","journal-title":"Neuroprotection"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/cns.13620","article-title":"Microglial\/Macrophage polarization and function in brain injury and repair after stroke","volume":"27","author":"Lyu","year":"2021","journal-title":"CNS Neurosci. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Seo, J.H., Yu, J.H., Suh, H., Kim, M.S., and Cho, S.R. (2013). Fibroblast growth factor-2 induced by enriched environment enhances angiogenesis and motor function in chronic hypoxic-ischemic brain injury. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0074405"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/sj.jcbfm.9600034","article-title":"Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice","volume":"25","author":"Chen","year":"2005","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrneurol.2014.207","article-title":"Microglial and macrophage polarization\u2014New prospects for brain repair","volume":"11","author":"Hu","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00401-015-1513-1","article-title":"Astrocytes: A central element in neurological diseases","volume":"131","author":"Pekny","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Zhu, H., Hu, S., Li, Y., Sun, Y., Xiong, X., Hu, X., Chen, J., and Qiu, S. (2022). Interleukins and Ischemic Stroke. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.828447"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.4103\/NRR.NRR-D-24-00568","article-title":"PI3K\/AKT signaling and neuroprotection in ischemic stroke: Molecular mechanisms and therapeutic perspectives","volume":"20","author":"Liu","year":"2024","journal-title":"Neural Regen. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/ana.20845","article-title":"Cellular and molecular mechanisms of neural repair after stroke: Making waves","volume":"59","author":"Carmichael","year":"2006","journal-title":"Ann. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nbd.2009.11.009","article-title":"Promoting axonal rewiring to improve outcome after stroke","volume":"37","author":"Benowitz","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrn2735","article-title":"Plasticity during stroke recovery: From synapse to behaviour","volume":"10","author":"Murphy","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","article-title":"Neurotrophins: Roles in Neuronal Development and Function","volume":"24","author":"Huang","year":"2001","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrn2699","article-title":"Experience-dependent structural synaptic plasticity in the mammalian brain","volume":"10","author":"Holtmaat","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/1545968312440745","article-title":"Getting neurorehabilitation right: What can be learned from animal models?","volume":"26","author":"Krakauer","year":"2012","journal-title":"Neurorehabil. Neural Repair"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The Classical Complement Cascade Mediates CNS Synapse Elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2174\/1570159X19666210610093658","article-title":"Pathways Involved in Remyelination after Cerebral Ischemia","volume":"20","author":"Wandosell","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"106200","DOI":"10.1016\/j.nbd.2023.106200","article-title":"New insights into the roles of oligodendrocytes regulation in ischemic stroke recovery","volume":"184","author":"Huang","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nn.3469","article-title":"Microglia in remyelination","volume":"16","author":"Miron","year":"2013","journal-title":"Nat. Neurosci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1474-4422(09)70016-X","article-title":"Matrix metalloproteinases","volume":"8","author":"Rosenberg","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","article-title":"Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises","volume":"21","author":"Armulik","year":"2011","journal-title":"Dev. Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e14631","DOI":"10.1111\/cns.14631","article-title":"No-reflow phenomenon","volume":"30","author":"Jia","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Fang, S., Huang, W., Qu, X., and Chai, W. (2024). Mitochondria in ischemia. Front. Neurosci., 18.","DOI":"10.3389\/fnins.2024.1500647"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.redox.2018.03.002","article-title":"Mitochondria in stroke","volume":"16","author":"Yang","year":"2018","journal-title":"Redox Biol."},{"key":"ref_66","first-page":"101883","article-title":"Mitochondrial mechanisms","volume":"77","author":"Saini","year":"2024","journal-title":"Mitochondrion"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s42466-024-00355-y","article-title":"Thrombo-inflammatory mechanisms","volume":"6","author":"Stoll","year":"2024","journal-title":"Neurol. Res. Pract."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/CIRCRESAHA.120.316655","article-title":"Platelet activity in stroke","volume":"127","author":"Schuhmann","year":"2020","journal-title":"Circ. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1161\/01.STR.29.10.2189","article-title":"Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain","volume":"29","author":"Rosenberg","year":"1998","journal-title":"Stroke"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/glia.20169","article-title":"Multiple roles for MMPs and TIMPs in cerebral ischemia","volume":"50","author":"Cunningham","year":"2005","journal-title":"Glia"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Reiter, R.J., Sharma, R., Rosales-Corral, S.A., Coto-Montes, A., Boga, J.A., and Vriend, J. (2020). Advances in Characterizing Recently-Identified Molecular Actions of Melatonin: Clinical Implications. Approaching Complex Diseases, Springer.","DOI":"10.1007\/978-3-030-32857-3_14"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1749-6632.2002.tb02096.x","article-title":"Melatonin reduces oxidant damage and promotes mitochondrial respiration: Implications for aging","volume":"959","author":"Reiter","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.lfs.2004.03.003","article-title":"Melatonin and mitochondrial function","volume":"75","author":"Leon","year":"2004","journal-title":"Life Sci."},{"key":"ref_74","first-page":"423","article-title":"The modulatory role of melatonin on immune responsiveness","volume":"7","author":"Reiter","year":"2006","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"18886","DOI":"10.3390\/molecules201018886","article-title":"Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism","volume":"20","author":"Tan","year":"2015","journal-title":"Molecules"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.aah4968","article-title":"Mechanisms linking circadian clocks, sleep, and neurodegeneration","volume":"354","author":"Musiek","year":"2016","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","article-title":"The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease","volume":"96","author":"Iadecola","year":"2017","journal-title":"Neuron"},{"key":"ref_80","unstructured":"Guerrero, J.M., Carrillo-Vico, A., and Lardone, P.J. (2007). La Melatonina. Investig. Cienc., 30\u201339."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1152\/physiol.00011.2014","article-title":"Melatonin: Exceeding expectations","volume":"29","author":"Reiter","year":"2014","journal-title":"Physiology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jxb\/err256","article-title":"Functional roles of melatonin in plants, and perspectives in nutritional and agricultural science","volume":"63","author":"Tan","year":"2012","journal-title":"J. Exp. Bot."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1124\/pr.110.002832","article-title":"International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors","volume":"62","author":"Dubocovich","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1111\/bph.13950","article-title":"Melatonin receptors: Molecular pharmacology and signalling in the context of system bias: Melatonin receptor system bias","volume":"175","author":"Cecon","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/bph.12457","article-title":"Melatonin MT1 and MT2 receptors display different molecular pharmacologies only in the G-protein coupled state","volume":"171","author":"Legros","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Chattree, V., Singh, K., Singh, K., Goel, A., Maity, A., and Lone, A. (2022). A comprehensive review on modulation of SIRT1 signaling pathways in the immune system of COVID-19 patients by phytotherapeutic melatonin and epigallocatechin-3-gallate. J. Food Biochem., 46.","DOI":"10.1111\/jfbc.14259"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/2277-9175.194801","article-title":"The effect of melatonin on endothelial dysfunction in patient undergoing coronary artery bypass grafting surgery","volume":"5","author":"Javanmard","year":"2016","journal-title":"Adv. Biomed. Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbi.2021.01.034","article-title":"Anti-inflammatory effects of melatonin: A systematic review and meta-analysis of clinical trials","volume":"93","author":"Cho","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/00004647-199908000-00001","article-title":"Inflammatory mediators and stroke: New opportunities for novel therapeutics","volume":"19","author":"Barone","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.freeradbiomed.2017.01.005","article-title":"Ischemic brain injury: New insights on the protective role of melatonin","volume":"104","author":"Ramos","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJM199704033361418","article-title":"Variable Bioavailability of Oral Melatonin","volume":"336","author":"Di","year":"1997","journal-title":"Engl. J. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00228-015-1873-4","article-title":"Clinical pharmacokinetics of melatonin: A systematic review","volume":"71","author":"Andersen","year":"2015","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1016\/S0021-9258(19)76431-X","article-title":"The fate of melatonin in animals","volume":"236","author":"Kopin","year":"1961","journal-title":"J. Biol. Chem."},{"key":"ref_94","first-page":"116","article-title":"Bioavailability of Long Acting Capsules of Melatonin in Mexican Healthy Volunteers","volume":"2","year":"2010","journal-title":"J. Biotechnol. Biomater."},{"key":"ref_95","unstructured":"European Medicines Agency (EMA) (2026, June 07). Assessment Report for Circadin (Melatonin), Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-discussion\/circadin-epar-scientific-discussion_en.pdf."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Andersen, L.P.H., Werner, M.U., Rosenkilde, M.M., Harps\u00f8e, N.G., Fuglsang, H., Rosenberg, J., and G\u00f6genur, I. (2016). Pharmacokinetics of oral and intravenous melatonin in healthy volunteers. BMC Pharmacol. Toxicol., 17.","DOI":"10.1186\/s40360-016-0052-2"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/1099-081X(200001)21:1<15::AID-BDD215>3.0.CO;2-H","article-title":"Bioavailability of melatonin in humans after day-time administration of D(7) melatonin","volume":"21","author":"Fourtillan","year":"2000","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0006-8993(97)00188-1","article-title":"Melatonin administration protects CA1 hippocampal neurons after transient forebrain ischemia in rats","volume":"755","author":"Cho","year":"1997","journal-title":"Brain Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-079X.1997.tb00331.x","article-title":"Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones unguiculatus)","volume":"23","author":"Guerrero","year":"1997","journal-title":"J. Pineal Res."},{"key":"ref_100","first-page":"185","article-title":"Opposite effects of pinealectomy and melatonin administration on brain damage following cerebral focal ischemia in rat","volume":"13","author":"Joo","year":"1998","journal-title":"Restor. Neurol. Neurosci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1034\/j.1600-0633.2002.290404.x","article-title":"Protective effects of melatonin in ischemic brain injury","volume":"29","author":"Cuzzocrea","year":"2000","journal-title":"J. Pineal Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0188-4409(01)00268-5","article-title":"Neuroprotective effect of melatonin on brain damage induced by acute global cerebral ischemia in cats","volume":"32","author":"Cervantes","year":"2001","journal-title":"Arch. Med. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neulet.2007.06.050","article-title":"Long-term study of dendritic spines from hippocampal CA1 pyramidal cells, after neuroprotective melatonin treatment following global cerebral ischemia in rats","volume":"423","author":"Cervantes","year":"2007","journal-title":"Neurosci. Lett."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-079X.2006.00395.x","article-title":"Long-term morphological and functional evaluation of the neuroprotective effects of post-ischemic treatment with melatonin in rats","volume":"42","author":"Cervantes","year":"2007","journal-title":"J. Pineal Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neulet.2008.10.043","article-title":"Long-term evaluation of cytoarchitectonic characteristics of prefrontal cortex pyramidal neurons, following global cerebral ischemia and neuroprotective melatonin treatment, in rats","volume":"448","author":"Cervantes","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00004647-199905000-00005","article-title":"Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia","volume":"19","author":"Kilic","year":"1999","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-2999(01)01253-5","article-title":"Effect of melatonin on ischemia reperfusion injury induced by middle cerebral artery occlusion in rats","volume":"428","author":"Sinha","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1034\/j.1600-079x.2002.1o847.x","article-title":"Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model","volume":"32","author":"Pei","year":"2003","journal-title":"J. Pineal Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1600-079X.2003.00093.x","article-title":"Delayed treatment with melatonin enhances electrophysiological recovery following transient focal cerebral ischemia in rats","volume":"36","author":"Lee","year":"2004","journal-title":"J. Pineal Res."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Wang, K., Ru, J., Zhang, H., Chen, J., Lin, X., Lin, Z., Wen, C., Wu, X., Lin, B., and Huang, L. (2020). Melatonin enhances the therapeutic effect of plasma exosomes against cerebral ischemia-induced pyroptosis through the TLR4\/NF-\u03baB pathway. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.00848"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"16105","DOI":"10.18632\/aging.203137","article-title":"Melatonin protects against focal cerebral ischemia-reperfusion injury in diabetic mice by ameliorating mitochondrial impairments: Involvement of the Akt-SIRT3-SOD2 signaling pathway","volume":"13","author":"Liu","year":"2021","journal-title":"Aging"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s10571-021-01122-2","article-title":"Modulation of \u03b17nAChR by melatonin alleviates ischemia- and reperfusion-compromised integrity of the blood\u2013brain barrier through inhibiting HMGB1-mediated microglia activation and CRTC1-mediated neuronal loss","volume":"42","author":"Chen","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-079X.2008.00586.x","article-title":"Melatonin preserves fetal growth in rats by protecting against ischemia\/reperfusion-induced oxidative\/nitrosative mitochondrial damage in the placenta","volume":"45","author":"Nagai","year":"2008","journal-title":"J. Pineal Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1750-3639.2008.00156.x","article-title":"Melatonin attenuates hypoxia-induced ultrastructural changes and increased vascular permeability in the developing hippocampus","volume":"18","author":"Kaur","year":"2008","journal-title":"Brain Pathol."},{"key":"ref_115","first-page":"771","article-title":"Histological study of the protective effect of melatonin on neural cells after neonatal hypoxia-ischemia","volume":"27","author":"Alvarez","year":"2012","journal-title":"Histol. Histopathol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/BF02253360","article-title":"Actions of melatonin in the reduction of oxidative stress: A review","volume":"7","author":"Reiter","year":"2000","journal-title":"J. Biomed. Sci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1096\/fj.03-1031fje","article-title":"Direct inhibition of the mitochondrial permeability transition pore: A possible mechanism responsible for anti-apoptotic effects of melatonin","volume":"18","author":"Andrabi","year":"2004","journal-title":"FASEB J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"114933","DOI":"10.1016\/j.taap.2020.114933","article-title":"Melatonin\u2019s efficacy in stroke patients; a matter of dose? A systematic review","volume":"392","author":"Ramos","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.amjcard.2017.05.018","article-title":"Usefulness of Early Treatment With Melatonin to Reduce Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention (From the Melatonin Adjunct in the Acute Myocardial Infarction Treated With Angioplasty Trial","volume":"120","author":"Piccolo","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.arcmed.2018.12.004","article-title":"Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis","volume":"49","author":"Ortiz","year":"2018","journal-title":"Arch. Med. Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jocn.2022.10.006","article-title":"Melatonin supplementation may benefit patients with acute ischemic stroke not eligible for reperfusion therapies: Results of a pilot study","volume":"106","author":"Mehrpooya","year":"2022","journal-title":"J. Clin. Neurosci."},{"key":"ref_122","first-page":"471","article-title":"Clinical investigation of protective effects of melatonin on patients with acute ischemic stroke","volume":"11","author":"Rabiee","year":"2025","journal-title":"Arch. Anesth. Crit. Care"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ijcard.2016.07.108","article-title":"Melatonin effects on myocardial ischemia\u2013reperfusion injury: Impact on the outcome in patients undergoing coronary artery bypass grafting surgery","volume":"221","author":"Dwaich","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/jpi.12138","article-title":"Melatonin reduces cardiac morbidity and markers of myocardial ischemia after elective abdominal aortic aneurism repair: A randomized, placebo-controlled, clinical trial","volume":"57","author":"Reiter","year":"2014","journal-title":"J. Pineal Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1034\/j.1600-079X.2001.310409.x","article-title":"Increased levels of malondialdehyde and nitrite\/nitrate in the blood of asphyxiated newborns: Reduction by melatonin","volume":"31","author":"Fulia","year":"2001","journal-title":"J. Pineal Res."},{"key":"ref_126","first-page":"1233","article-title":"Role of melatonin in management of hypoxic ischaemic encephalopathy in newborns: A randomized controlled trial","volume":"68","author":"Ahmad","year":"2018","journal-title":"J. Pak. Med. Assoc."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/jp.2014.186","article-title":"Melatonin use for neuroprotection in perinatal asphyxia: A randomized controlled pilot study","volume":"35","author":"Aly","year":"2015","journal-title":"J. Perinatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/jrpp.JRPP_17_49","article-title":"Melatonin supplementation may improve the outcome of patients with hemorrhagic stroke in the intensive care unit","volume":"6","author":"Dianatkhah","year":"2017","journal-title":"J. Res. Pharm. Pract."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1600-079X.2010.00835.x","article-title":"Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome","volume":"50","author":"Poliwczak","year":"2011","journal-title":"J. Pineal Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12265-017-9768-7","article-title":"Effect of Intracoronary and Intravenous Melatonin on Myocardial Salvage Index in Patients with ST-Elevation Myocardial Infarction: A Randomized Placebo Controlled Trial","volume":"10","author":"Ekeloef","year":"2017","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_131","first-page":"26","article-title":"Melatonin in the combined treatment of cardiovascular diseases","volume":"88","author":"Zaslavskaia","year":"2010","journal-title":"Klin. Med."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Shafiei, E., Bahtoei, M., Raj, P., Ostovar, A., Iranpour, D., Akbarzadeh, S., Shahryari, H., Anvaripour, A., Tahmasebi, R., and Netticadan, T. (2018). Effects of N-acetyl cysteine and melatonin on early reperfusion injury in patients undergoing coronary artery bypass grafting: A randomized, open-labeled, placebo-controlled trial. Medicine, 97.","DOI":"10.1097\/MD.0000000000011383"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Zhao, Z., Lu, C., Li, T., Wang, W., Ye, W., Zeng, R., Ni, L., Lai, Z., Wang, X., and Liu, C. (2018). The protective effect of melatonin on brain ischemia and reperfusion in rats and humans: In vivo assessment and a randomized controlled trial. J. Pineal Res., 65.","DOI":"10.1111\/jpi.12521"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/jcph.592","article-title":"Pharmacokinetics of high-dose intravenous melatonin in humans","volume":"56","author":"Andersen","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Wade, A.G., Ford, I., Crawford, G., McConnachie, A., Nir, T., and Laudon, M. (2010). Melatonin and insomnia. BMC Med., 8.","DOI":"10.1186\/1741-7015-8-51"},{"key":"ref_136","unstructured":"European Medicines Agency (EMA) (2026, June 07). Assessment Report: Slenyto (Melatonin), Available online: https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/slenyto-epar-public-assessment-report_en.pdf."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1185\/03007995.2010.537317","article-title":"Prolonged release melatonin in the treatment of primary insomnia: Evaluation of the age cut-off for short- and long-term response","volume":"27","author":"Wade","year":"2011","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaac.2019.12.007","article-title":"Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder","volume":"60","author":"Malow","year":"2021","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jaac.2017.09.414","article-title":"Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder","volume":"56","author":"Gringras","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.38731.532766.F6","article-title":"Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: Meta-analysis","volume":"332","author":"Buscemi","year":"2006","journal-title":"BMJ"},{"key":"ref_141","unstructured":"Gringras, P., and Findling, R.L. (2026, June 07). Efficacy and Safety of Circadin\u00ae in the Treatment of Sleep Disturbances in Children with Neurodevelopment Disabilities; ClinicalTrials.gov Identifier: NCT01906866, Available online: https:\/\/clinicaltrials.gov\/study\/NCT01906866."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1517\/14656566.2012.667076","article-title":"Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia","volume":"13","author":"Lemoine","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_143","first-page":"577","article-title":"Effect of melatonin on nocturnal blood pressure: Meta-analysis of randomized controlled trials","volume":"7","author":"Grossman","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"ref_145","first-page":"3851","article-title":"Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders","volume":"24","author":"Rueda","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jxb\/ern284","article-title":"Phytomelatonin: A review","volume":"60","author":"Paredes","year":"2009","journal-title":"J. Exp. Bot."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s10571-017-0461-9","article-title":"Neuroprotective Mechanisms of Melatonin in Hemorrhagic Stroke","volume":"37","author":"Wu","year":"2017","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_148","unstructured":"European Medicines Agency (EMA) (2026, June 07). EU\/3\/21\/2468\u2014Orphan Designation for Treatment of Non-Traumatic Spontaneous Intracerebral Haemorrhage (Melatonin). Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/orphan-designations\/eu-3-21-2468#overview."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/12\/1084\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T09:55:07Z","timestamp":1781603707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/12\/1084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":148,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cells15121084"],"URL":"https:\/\/doi.org\/10.3390\/cells15121084","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}